Show simple item record

Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study

dc.contributor.authorUstundag, Kasim
dc.contributor.authorDurak, Merih Guray
dc.contributor.authorZEKİOĞLU, OSMAN
dc.contributor.authorYavuz, Ekrem
dc.contributor.authorIlvan, Sennur
dc.contributor.authorDemir, Atakan
dc.contributor.authorOnur, Handan
dc.contributor.authorTuzlali, Sitki
dc.contributor.authorGoktas, Burce
dc.contributor.authorCANDA, TÜLAY
dc.contributor.authorÖZDEMİR, NECMETTİN
dc.contributor.authorDizbay, Serpil Sak
dc.date.accessioned2021-03-05T18:19:49Z
dc.date.available2021-03-05T18:19:49Z
dc.date.issued2018
dc.identifier.citationCANDA T., Yavuz E., ÖZDEMİR N., Ilvan S., Dizbay S. S. , Durak M. G. , Tuzlali S., ZEKİOĞLU O., Demir A., Onur H., et al., "Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study", EUROPEAN JOURNAL OF BREAST HEALTH, cilt.14, ss.160-165, 2018
dc.identifier.otherav_c9d5b4c4-300b-45bd-9297-245ee4971b7a
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/133725
dc.identifier.urihttps://doi.org/10.5152/ejbh.2018.3961
dc.description.abstractObjective: As patients with increased human epidermal growth factor receptor (HER2) overexpression are more likely to benefit from trastuzumab treatment, the accuracy of HER2 receptor status in breast cancer patients is significant for appropriate disease management. However, this assessment is not harmonized and results may be highly variable between centers. The aim of this study was to investigate the degree of interlaboratory variability in the results of HER2 expression reported by 5 participating centers and to assess the concordance between these centers and a reference laboratory.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectONKOLOJİ
dc.titleImmunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF BREAST HEALTH
dc.contributor.departmentDokuz Eylül Üniversitesi , ,
dc.identifier.volume14
dc.identifier.issue3
dc.identifier.startpage160
dc.identifier.endpage165
dc.contributor.firstauthorID254588


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record